Alere Challenges Medicare Billing Block
The company, which had its Medicare supplier billing number revoked in November, filed an appeal with an administrative law judge. Alere also asked the US District Court for the District of Columbia to force CMS to allow its Arriva unit to stay in the competitive bidding program while the ALJ appeal is pending.
You may also be interested in...
Alere subsidiary Arriva Medical routinely gave Medicare beneficiaries glucometers they didn’t need and billed the government for them, a recently unsealed lawsuit claims.
The European Commission has approved Abbott Laboratories' pending acquisition of Alere, on condition that Alere's Epoc, Triage and BNP businesses are divested to alleviate anti-trust concerns. However, Abbott is still looking to cut loose from the $5.8bn deal.
Abbott has asked a Delaware court to cancel its agreement to buy Alere for $5.8bn based on a series of financial and regulatory missteps by Alere. Alere, which earlier sued to force the merger to go through, plans to fight the suit.